Aratana therapeutics investorroom investor overview. Aratana therapeutics granted full license for at004 by usda. Eating less picking at food or taking more time to eat. Additionally, aratana therapeutics has registered 37 trademarks with the most popular class being. Mar, 2019 the following information was filed by aratana therapeutics, inc. Resolved, that the compensation paid to the named executive officers of aratana therapeutics, inc. About aratana therapeutics aratana therapeutics is a pet therapeutics company focused on licensing, developing and commercializing innovative therapeutics for dogs and cats. For additional information about adverse drug experience reporting. Petx stock, price quote and chart, trading and investing tools. Heres why our investors think you should check out edge therapeutics, aratana therapeutics, and alkermes. Aratana therapeutics to be acquired by elanco animal health. Additionally, aratana therapeutics has registered 37 trademarks with the most popular class being pharmaceutical, veterinary and sanitary products.
Aratana therapeutics petx presents at barclays global. Elan, today finalized the acquisition of aratana therapeutics nasdaq. Federal usa law restricts this drug to use by or on the order of a licensed veterinarian. Petx is a pet therapeutics company focused on the development and commercialization of innovative therapeutics for dogs and cats. Print your org chart in pdf aratana therapeutics org chart download your org chart in excel aratana therapeutics org chart. Dec 23, 20 aratana believes the development and commercialization of these therapeutics will permit veterinarians and pet owners to manage pets medical needs safely and effectively, resulting in longer and. Aratana therapeutics inc is a developmentstage biopharmaceutical company. Data sheet sds or for technical assistance, call aratana therapeutics at 18446405500.
Aratana therapeutics provides product updates biospace. Free forex prices, toplists, indices and lots more. Petx, a pet therapeutics company focused on the development and commercialization of innovative therapeutics for dogs and cats, today announced the voting results for the three proposals considered and voted upon by its stockholders at its special meeting on july 16, 2019. Aratana therapeutics provides update on entyce biospace. Petx has received topline pivotal field effectiveness study results for at016, an investigational adiposederived allogeneic stem cell therapeutic candidate. See insights on aratana therapeutics including office locations, competitors, revenue, financials, executives, subsidiaries and. Sitemap outlines more about aratana and our therapeutics. In 2017, aratana therapeutics received a conditional license from the united states department of agricultures center for veterinary biologics.
Aratana therapeutics, a wholly owned subsidiary of elanco animal health, is a pioneer in pet therapeutics focused on licensing, developing and. Its main activity is the licensing, developing, and commercializing of innovative biopharmaceutical products for companion animals. Aratana believes that it can leverage the investment in the human biopharmaceutical industry to bring therapeutics to dogs and cats in a capital and time efficient manner. Cancer strikes pets, too, and lymphoma is one of the most common in dogs. Elanco finalizes acquisition of aratana therapeutics. Jan 26, 2016 aratana therapeutics files for first fda approval. The intellectual property of aratana therapeutics includes 9 registered patents primarily in the medical or veterinary science. Aratana therapeutics s earnings per share without nonrecurring items for the three months ended in mar. Aratana therapeutics company profile office locations. Get breaking news and analysis on aratana therapeutics, inc. The following slide deck was published by aratana therapeutics, inc. Aratana therapeutics mission is to successfully develop and deliver bestinclass therapeutics, provide comprehensive service to veterinarians and serve as a collaborator of choice. It is engaged in licensing, development and commercialization of prescription medicines for pets.
Notice is hereby given that a class action lawsuit has been filed on behalf of those who purchased or otherwise acquired aratana therapeutics, inc. Earnings for aratana therapeutics are expected to decrease by 79. Our strategy is to become the leading provider of therapeutics developed and approved specifically for the treatment of unmet medical needs in pets. Petx, a pet therapeutics company focused on the licensing, development and commercialization of innovative biopharmaceutical products for companion animals, today provided several product updates. Add to portfolio email alerts stock pdf rss website filings download excel batch download p. Aratana therapeutics inc does not currently have any hardcopy reports on. The organizational chart of aratana therapeutics displays its 7 main executives including craig tooman. Apr 25, 2017 aratana therapeutics is a pet therapeutics company focused on licensing, developing and commercializing innovative therapeutics for dogs and cats. Its earnings per share without nonrecurring items for the trailing twelve months ttm ended in mar.
Mar 14, 2019 the following slide deck was published by aratana therapeutics, inc. Mar 16, 2015 rosen law firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of aratana therapeutics, inc securities nasdaq. Striving for three fda approvals in 2016 just a few months ago, in december 2015, aratana therapeutics reached a major milestone their fifth anniversary. Aratana believes that it can leverage the investment in the human. Petx was a big mover last session, as the company saw its shares rise more than 12% on the day. Petx stock rating and analysis aratana therapeutics. If you wish to see the entire case, please consult pacer directly.
Aratana therapeutics inc is a pet therapeutics company. Aratana therapeutics inc has reached its limit for free report views. The following information was filed by aratana therapeutics, inc. Petx, a pet therapeutics company focused on developing and commercializing innovative therapeutics for dogs and cats, and developer of the firstofitskind canine nsaid for osteoarthritis, galliprant.
Aratana therapeutics granted full license for at004 by. About aratana therapeutics aratana is a pet therapeutics company focused on developing and commercializing innovative therapeutics for dogs and cats. About aratana how were bringing innovation to veterinary medicine. These statements are neither promises nor guarantees, but involve known and. Petx fundamental charts price to book value fundamental charts the style scores are a complementary set. Today, you can download 7 best stocks for the next 30 days. Total assets quarterly is a widely used stock evaluation measure. The board of directors the board of aratana therapeutics, inc.
Aratana therapeutics investorroom corporate governance. Elanco announces agreement to acquire aratana therapeutics. One of the key data points that goes into the price an option buyer is. At the celebration, the company reminisced about the past and focused on looking forward to 2016, a year of new beginnings for the company. Vaccine strain listeria monocytogenes abscess in a dog. From 2012 to 2017, there were only four new chemical entities approved. Jan 06, 2015 aratana therapeutics is a pet therapeutics company focused on licensing, developing and commercializing innovative biopharmaceutical products for companion animals. Aratana therapeutics files for second fda approval firstinclass ghrelin agonist. Dogs, humans and lymphoma therapy nature biotechnology.
Entyce, the only fdaapproved veterinary therapeutic to. Petx quote overview charts aratana therapeutics, inc. Aratana petx reports q4 loss, misses revenue estimates. See insights on aratana therapeutics including office locations, competitors, revenue, financials, executives, subsidiaries and more at craft. Apr 26, 2019 aratana s mission is to find, develop and commercialize safe and effective therapeutics to enhance the quality of life and strengthen the bond between people and their pets. Any new closed out added to reduced no change restrict to hedge funds. Aratana therapeutics stockholders adopt merger agreement. Petx securities between march 16, 2015 and february 3, 2017, both dates inclusive the class period. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Petx stock quote aratana therapeutics inc bloomberg markets. Aratana therapeutics is a pet therapeutics company focused on licensing, developing and commercializing innovative biopharmaceutical products for companion animals. About aratana therapeuticsaratana therapeutics is a pet therapeutics company focused on developing and commercializing innovative therapeutics for dogs and cats. Aratana therapeutics is a pet therapeutics company focused on licensing, developing and commercializing innovative therapeutics for dogs and cats. For further discussion of these and other risks and uncertainties, see aratana s most recent form 10k and form 10q filings with the united states securities and exchange commission.
Petx, a pet therapeutics company focused on the licensing, development and commercialization of innovative. About aratana therapeutics aratana therapeutics is a pet therapeutics company focused on developing and commercializing innovative therapeutics for dogs and cats. Elanco, aratana announce marketing authorization of. The move came on solid volume too with far more shares changing hands. Feb 18, 2016 aratana therapeutics is a pet therapeutics company focused on licensing, developing and commercializing innovative biopharmaceutical products for companion animals. Delivering new beginnings for pets, for the people who. One of three aratana products to receive food and drug. Fdaapproved therapeutics for the management of surgical pain in dogs and cats. Form 10k html aratana therapeutics inc does not currently have any hardcopy reports on.
Aratana therapeutics files for first european approval. Aratana therapeutics petx reports study results for at016. Aratana therapeutics provides update on entyce marketwatch. Petx was a big mover last session, as the company saw its shares rise nearly 7% on the day. Investors in aratana therapeutics, inc petx saw new options begin trading this week, for the february 2020 expiration.
Click the button below to request a report when hardcopies become available. Visitors to the aratana therapeutics booth at iveccs were invited to preorder nocita and attend a saturday breakfast session featuring a presentation by jessica wofford, dvm, phd, aratana therapeutics, entitled postoperative pain in dogs. Pdf ghrelin is a hormone, secreted from cells in the stomach, which is. Aratana therapeutics, kc animal health corridor hunt for. Print your org chart in pdf aratana therapeutics org chart. Petx stock quote of aratana theraptcs investorplace. These forwardlooking statements are based on managements current expectations. Shareholder class action filed against aratana therapeutics, inc. Aratana introduced new advance for extended pain relief at. Additionally, aratana contributes two additional products to elancos portfolio. Heres why our investors think you should check out edge therapeutics, aratana therapeutics, and. Trading strategies a dynamic list of curated stocks that traders can buy within the next 10 business days and hold for a short period of time to collect their dividend without realizing the usual exdividend date price depreciation. Stock analysis for aratana therapeutics inc petx including stock price, stock chart, company news, key statistics, fundamentals and company profile. Petx stock news and research articles aratana therapeutics.
This transaction allows elanco to capture the full value of growing product. Petx stock quote aratana therapeutics inc bloomberg. All content is posted anonymously by employees working at aratana therapeutics. Whalewisdom has at least 71 form 4 filings the firm last filed a form d notice of exempt offering of securities on 201023. Petx news and headlines aratana therapeutics gurufocus. Pet new chemical entities defined by aratana as new chemical. Aratana therapeutics provides 20 development update. Home homepage membership levels membership data coverage complete stock list founders message the book value investing forum podcast free trial.
1273 478 1194 1572 535 1552 725 854 472 535 349 1424 1068 1010 562 1261 1028 243 1250 1024 1427 279 395 1293 106 710 164 1029 747 292 136 1382 870 776 834 67 723 4 682 328 64 1495